RSS   Newsletter   Contact   Advertise with us

Tevosol appoints Ron Mills as chief executive officer

Christian Fernsby | Edmonton, AB, Canada | June 17, 2019
TevosolTevosol, an early stage medical device company, announced the appointment of Ron Mills as the company's chief executive officer.
Mr. Mills brings more than 30 years of experience in healthcare communications, brand strategy, and venture creation, with 20 years in organ transplantation and regenerative medicine.

From 2000 to 2007 Mr. Mills led global market development and commercialization of the LifePort Kidney Transporter for Organ Recovery Systems, the market leader in organ preservation.

Mr. Mills earned degrees in literature at the University of Michigan.

Prior to joining Organ Recovery Systems, he was director of communications for the Chicago and Great Lakes consulting practice of Ernst and Young, an independent writer and editor, and a biopharma advertising executive.

In 2007 Mr. Mills founded Maelstream Startups, an independent consultancy based in Evanston, Illinois, where he served as launch strategist for drugs, devices, and dotcoms; as interim executive at Publicis, Syneos (InVentiv), and McCann; and as an advisor to the transplantation community.

Mr. Mills joined Tevosol in Edmonton, Alberta, Canada, in October 2018.